Description Usage Format Details
AHT trial data set: Randomized, placebo controlled, Double-blind, parallel study; Subjects randomized to Placebo and AHT in the ratio 1:1; Dose of AHT studied : 5mg Primary endpoint: Change from baseline blood pressure (systolic and diastolic) measured at 8 weeks. Details of the Data Column: ID=Subject ID, Age: Age(years), Weight : Weight(Kg), SCreatinine: Serum Creatinine(mg/dl), SerumALT: Serum Alanine aminotransferase(IU/L), DelDBP: Change from baseline diastolic blood pressure(mm Hg), DELSBP: Change from baseline systolic blood pressure (mm Hg), TRT: Treatment, Dose: Dose (microgram,µg)
1 |
A data frame with 100 rows and 11 variables
ID. Numerical ID (1–100)
AGE. Age in Years
WEIGHT Weight in Kg
SCREATININE. Serum creatinine in mg/dl
SERUMALT. Serum Alanine Aminotransferase in IU/L
GENDER. Male or Female gender identification
RACE. Ethnicity
DELDBP. Change from baseline in Diastolic blood pressure, mmHg
DELSBP. Change from baseline in Systolic blood pressure, mmHg
TRT. Treatment indicator: Placebo and AHT group
DOSE. Dose of AHT in ug
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.